• BARR PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2007 FY2006 FY2005 FY2004 FY2003
    Assets
    Cash and Short Term Investments 534.49 M 601.90 M 643.26 M 452.25 M 396.54 M
    Net Receivables 582.68 M 276.26 M 181.47 M 214.74 M 252.79 M
    Total Inventories 501.21 M 134.27 M 137.64 M 150.25 M 163.93 M
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses 70.87 M
    Other Current Assets 131.80 M 25.68 M 38.45 M 61.00 M 34.25 M
    Current Assets Total 1.75 B 1.11 B 1.00 B 878.25 M 847.50 M
    Long Term Receivables 0.00 4.75 M
    Investment in Unconsolidated Subsidiaries 750,000.00
    Other Investments 16.54 M 18.13 M 53.79 M 89.14 M 15.06 M
    Property, Plant & Equipment Net 1.12 B 275.96 M 249.48 M 236.83 M 223.52 M
    Property, Plant & Equipment Gross 1.44 B 439.62 M 379.10 M 343.48 M 323.83 M
    Accumulated Depreciation 325.09 M 163.66 M 129.62 M 106.65 M 100.31 M
    Other Assets 1.84 B 488.14 M 125.71 M 94.03 M 89.27 M
    Deferred Charges 194,000.00 1.85 M
    Tangible Other Assets 69.81 M 22.96 M 9.37 M 10.92 M 29.21 M
    Intangible Other Assets 1.77 B 465.18 M 116.34 M 83.11 M 60.07 M
    Total Assets 4.72 B 1.89 B 1.43 B 1.30 B 1.18 B
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 298.06 M 8.82 M 5.45 M 8.45 M 8.51 M
    Accrued Payroll 60.57 M
    Income Taxes Payable 39.07 M 9.34 M 13.35 M 20.14 M 11.32 M
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 229.52 M 99.21 M 151.89 M 117.97 M 66.11 M
    Current Liabilities Total 779.33 M 187.32 M 220.43 M 207.64 M 274.79 M
    Long Term Debt 1.78 B 7.43 M 15.49 M 32.36 M 34.03 M
    Provision for Risks & Charges 0.00 0.00
    Deferred Taxes 153.23 M -30.20 M -60.50 M -35.02 M -5.59 M
    Deferred Income 22.42 M 24.56 M
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 80.67 M 11.15 M -40.09 M 51.22 M 4.13 M
    Total Liabilities 2.82 B 200.26 M 195.83 M 256.21 M 307.35 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 38.15 M 41.10 M 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 1.87 B 1.69 B 1.23 B 1.04 B 868.00 M
    Common Stock 1.11 M 1.09 M 1.06 M 1.05 M 671,000.00
    Capital Surplus 681.69 M 574.78 M 454.49 M 377.02 M 326.00 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves
    Unappropriated (Free) Reserves
    Retained Earnings 1.01 B 1.22 B 879.67 M 664.68 M 542.21 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities 277.87 M -377,000.00 -561,000.00 0.00 -179,000.00
    Treasury Stock 100.69 M 100.69 M 100.69 M 708,000.00 708,000.00
    Total Liabilities & Shareholders Equity 4.72 B 1.89 B 1.43 B 1.30 B 1.18 B
    Common Shares Outstanding 107.81 M 106.21 M 103.37 M 104.50 M 100.18 M